Scopus Biopharma Inc (SCPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 362 | 1,402 | 125 | 311 | 1,157 |
| TOTAL | $496 | $1,601 | $390 | $413 | $1,670 |
| Non-Current Assets | |||||
| PPE Net | 2 | 2 | 2 | 3 | 3 |
| TOTAL | $2 | $2 | $2 | $3 | $3 |
| Total Assets | $498 | $1,603 | $392 | $416 | $1,673 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,909 | 9,152 | 7,202 | 5,920 | 5,371 |
| Other current liabilities | 93 | 162 | 253 | N/A | N/A |
| TOTAL | $11,002 | $9,313 | $7,454 | $5,920 | $5,371 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 312 | 230 | 0 | 0 | 0 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $11,002 | $9,313 | $7,454 | $5,920 | $5,371 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 42,084 | 39,784 | 39,584 | 21,094 | 21,094 |
| Common Shares | 40 | 40 | 21 | 21 | 21 |
| Retained earnings | -58,131 | -55,515 | -53,065 | -51,334 | -49,436 |
| Other shareholders' equity | -1,029 | -778 | -537 | -3 | -12 |
| TOTAL | $-10,505 | $-7,710 | $-7,062 | $-5,504 | $-3,698 |
| Total Liabilities And Equity | $498 | $1,603 | $392 | $416 | $1,673 |